lidocaine has been researched along with Cancer of the Uterus in 12 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess efficacy of two different techniques of lidocaine injection in the uterine arteries to reduce pain following uterine artery embolization (UAE) for leiomyomas." | 9.24 | Intraarterial Lidocaine for Pain Control in Uterine Artery Embolization: A Prospective, Randomized Study. ( Mironov, O; Noel-Lamy, M; Rajan, DK; Simons, ME; Sniderman, KW; Tan, KT, 2017) |
| "To evaluate whether administration of lidocaine into the uterine artery for anesthesia immediately after uterine artery embolization (UAE) with trisacryl gelatin microspheres (TAGM) for leiomyoma is safe and effective." | 7.96 | Intra-Arterial Lidocaine Administration for Anesthesia after Uterine Artery Embolization with Trisacryl Gelatin Microspheres for Leiomyoma. ( Asato, A; Katsumori, T; Kotera, Y; Miura, H; Seri, S; Yoshikawa, T, 2020) |
| "A modified protocol of uterine fibroid embolization (UFE) is proposed for alleviating the postinterventional pain." | 6.71 | Effectiveness of intra-arterial anesthesia for uterine fibroid embolization using dilute lidocaine. ( Han, H; Li, Y; Wang, G; Yang, Z; Zhan, S, 2005) |
| "To assess efficacy of two different techniques of lidocaine injection in the uterine arteries to reduce pain following uterine artery embolization (UAE) for leiomyomas." | 5.24 | Intraarterial Lidocaine for Pain Control in Uterine Artery Embolization: A Prospective, Randomized Study. ( Mironov, O; Noel-Lamy, M; Rajan, DK; Simons, ME; Sniderman, KW; Tan, KT, 2017) |
| "To evaluate whether administration of lidocaine into the uterine artery for anesthesia immediately after uterine artery embolization (UAE) with trisacryl gelatin microspheres (TAGM) for leiomyoma is safe and effective." | 3.96 | Intra-Arterial Lidocaine Administration for Anesthesia after Uterine Artery Embolization with Trisacryl Gelatin Microspheres for Leiomyoma. ( Asato, A; Katsumori, T; Kotera, Y; Miura, H; Seri, S; Yoshikawa, T, 2020) |
| "To reduce the severity of post procedure pain associated with uterine artery embolization (UAE) for leiomyomata, we used continuous infusion of low concentration ropivacaine through an epidural catheter." | 3.72 | [Pain control with epidural anesthesia for uterine artery embolization]. ( Chiba, A; Enomoto, A; Hayakawa, S; Saito, S; Toyoshima, M, 2004) |
| "Phenazopyridine has been associated with methemoglobinemia in patients who have received an overdose, have decreased renal function, or are discovered to be unusually susceptible to the drug (ie, they may have an undetected NADH methemoglobin reductase deficiency)." | 3.68 | Acquired methemoglobinemia from multiple oxidants. ( Bailey, MK; Baker, JD; Conroy, JM; Dorman, BH; Martin, WJ, 1993) |
| "The standard postoperative pain treatment consisted of oral analgesia with ibuprofen (400 mg) in liquid-filled capsules." | 2.73 | Preoperative analgesia with local lidocaine infiltration for abdominal hysterectomy pain management. ( Deutsch, M; Jakobi, P; Lowenstein, L; Paz, Y; Yaniv, D; Zimmer, EZ, 2008) |
| "A modified protocol of uterine fibroid embolization (UFE) is proposed for alleviating the postinterventional pain." | 2.71 | Effectiveness of intra-arterial anesthesia for uterine fibroid embolization using dilute lidocaine. ( Han, H; Li, Y; Wang, G; Yang, Z; Zhan, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Katsumori, T | 1 |
| Miura, H | 1 |
| Yoshikawa, T | 1 |
| Seri, S | 1 |
| Kotera, Y | 1 |
| Asato, A | 1 |
| Solano Calvo, JA | 1 |
| Del Valle Rubido, C | 1 |
| Rodríguez-Miguel, A | 1 |
| de Abajo, FJ | 1 |
| Delgado Espeja, JJ | 1 |
| González Hinojosa, J | 1 |
| Fernández Muñoz, L | 1 |
| Zapico Goñi, Á | 1 |
| Selvi, O | 1 |
| Tulgar, S | 1 |
| Noel-Lamy, M | 1 |
| Tan, KT | 1 |
| Simons, ME | 1 |
| Sniderman, KW | 1 |
| Mironov, O | 1 |
| Rajan, DK | 1 |
| Saito, S | 1 |
| Chiba, A | 1 |
| Hayakawa, S | 1 |
| Toyoshima, M | 1 |
| Enomoto, A | 1 |
| Zhan, S | 1 |
| Li, Y | 1 |
| Wang, G | 1 |
| Han, H | 1 |
| Yang, Z | 1 |
| Lowenstein, L | 1 |
| Zimmer, EZ | 1 |
| Deutsch, M | 1 |
| Paz, Y | 1 |
| Yaniv, D | 1 |
| Jakobi, P | 1 |
| Nadkarni, AV | 1 |
| Tondare, AS | 1 |
| Conroy, JM | 1 |
| Baker, JD | 1 |
| Martin, WJ | 1 |
| Bailey, MK | 1 |
| Dorman, BH | 1 |
| Keyoung, JA | 1 |
| Levy, EB | 1 |
| Roth, AR | 1 |
| Gomez-Jorge, J | 1 |
| Chang, TC | 1 |
| Spies, JB | 1 |
| Ebert, A | 1 |
| Goetze, B | 1 |
| Hasson, HM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Efficacy Between Nitrous Oxide (n2o) Analgesia and Pericervical Analgesia in Outpatient Operative Hysteroscopy With Miniresector: a Randomized Clinical Pilot Study[NCT06092541] | 50 participants (Anticipated) | Interventional | 2023-10-02 | Recruiting | |||
| Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization : a Single-center Prospective Randomized Study[NCT02293447] | Phase 4 | 60 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| Effect of Intraperitoneal Bupivacaine on Postoperative Pain Control in Patients Undergoing Pelvic Organ Prolapse Repair[NCT06120530] | Phase 4 | 90 participants (Anticipated) | Interventional | 2023-08-15 | Recruiting | ||
| Use of Preemptive Pudendal Nerve Block Prior to Hydrodistension for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): a Prospective, Double-blinded, Randomized Control Trial[NCT02517996] | 18 participants (Actual) | Interventional | 2015-02-28 | Terminated (stopped due to Preliminary results were promising when interim analysis performed but terminated due to primary investigators left recruitment site.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"To determine the change in interstitial cystitis symptom index at baseline, 2 hours, 2 weeks, 6 weeks and 3 months after hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline).~The IC symptom index questionnaire consists of 4 questions on IC symptoms. 2 of the questions have 6 answer choices ranging from 0-never, to 5-almost always. 1 question has 6 answer choices ranging from 0-never to 5-usually. 1 question has 7 answer choices ranging from 0-never to 6-5 or more times. The numerical score for each question are added together, with a minimum score of 0 and a maximum score of 21. A higher score indicates greater severity of IC symptoms." (NCT02517996)
Timeframe: Baseline, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline | 2 weeks | 6 weeks | 12 weeks | |
| 1% Lidocaine | 12.5 | 11.43 | 11.8 | 10 |
| Normal Saline | 10 | 9 | 8.67 | 5 |
"To determine the change in pain at 2 hours, 2 weeks, 6 weeks, and 3 months postoperatively in patients undergoing hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline) using the visual analog scale (VAS).~VAS consists of a 10cm horizontal line with the minimum endpoint labeled no pain (0) and maximum labeled worst pain ever (10). Patients placed a mark on the point that corresponds to the level of pain severity they felt. The cm distance from the low end of the VAS to the patient's mark is used as the numerical index of the intensity of pain. Pain scores of 3.0-5.4 cm are moderate, over 5.4 indicates severe pain." (NCT02517996)
Timeframe: Baseline, 2 hours, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | ||||
|---|---|---|---|---|---|
| Pre operative VAS score | Post operative VAS score | 2 week post operative VAS scores | 6 week post operative VAS score | 12 weeks post operative VAS score | |
| 1% Lidocaine | 3.125 | 3.75 | 2.7 | 3 | 2.6 |
| Normal Saline | 4.5 | 5 | 4.8 | 4.33 | 2 |
"To determine the change in pelvic urgency, pain and frequency (PUF) questionnaire at baseline, 2 hours, 2 weeks, 6 weeks and 3 months after hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline).~The Pelvic Urgency, Pain, and Frequency Patient Symptom Scale asks 11 questions, 7 on PUF symptoms, 4 on how bothersome PUF symptoms are. Symptom questions include 3, 4, or 5 ranked answers, with higher answers indicating more voids, or greater frequency of pain. The bother questions each of 4 ranked answers from 0-never, to 3-always. The symptom score is added, the bother score is added, and then the total score is added. The total PUF score is then reported. The minimum score is 0 and the maximum score is 35, and a higher score indicates greater symptoms and higher bother from pelvic pain and frequency." (NCT02517996)
Timeframe: Baseline, 2 hours, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline | 2 weeks | 6 weeks | 12 weeks | |
| 1% Lidocaine | 22.63 | 18.83 | 18.2 | 17.2 |
| Normal Saline | 19 | 17.4 | 16.7 | 14 |
"To determine the change in problem index (O'Leary Sant) at baseline, 2 hours, 2 weeks, 6 weeks and 3 months after hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline).~The IC problem index questionnaire consists of 4 questions on how much of a problem a patient's IC symptoms cause them. Each question has 5 answer choices ranging from 0-no problem, to 4-big problem. The numerical score for each question are added together, with a minimum score of 0 and a maximum score of 16. A higher score indicates that IC symptoms cause more problems for the patient." (NCT02517996)
Timeframe: Baseline, 2 hours, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline | 2 weeks | 6 weeks | 12 weeks | |
| 1% Lidocaine | 11.75 | 9.71 | 10 | 9.6 |
| Normal Saline | 9.43 | 8.6 | 7.33 | 6 |
5 trials available for lidocaine and Cancer of the Uterus
| Article | Year |
|---|---|
Nitrous oxide versus lidocaine versus no analgesic for in-office hysteroscopy: a randomised clinical trial.
Topics: Adult; Ambulatory Care; Anesthetics, Inhalation; Anesthetics, Local; Biopsy; Female; Humans; Hystero | 2021 |
Intraarterial Lidocaine for Pain Control in Uterine Artery Embolization: A Prospective, Randomized Study.
Topics: Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Analysis of Variance; Anesthetics, Local; Femal | 2017 |
Effectiveness of intra-arterial anesthesia for uterine fibroid embolization using dilute lidocaine.
Topics: Adolescent; Adult; Analgesics; Anesthetics, Local; Embolization, Therapeutic; Female; Humans; Inject | 2005 |
Preoperative analgesia with local lidocaine infiltration for abdominal hysterectomy pain management.
Topics: Adult; Anesthetics, Local; Female; Humans; Hysterectomy; Leiomyoma; Lidocaine; Middle Aged; Pain, Po | 2008 |
Preoperative analgesia with local lidocaine infiltration for abdominal hysterectomy pain management.
Topics: Adult; Anesthetics, Local; Female; Humans; Hysterectomy; Leiomyoma; Lidocaine; Middle Aged; Pain, Po | 2008 |
Preoperative analgesia with local lidocaine infiltration for abdominal hysterectomy pain management.
Topics: Adult; Anesthetics, Local; Female; Humans; Hysterectomy; Leiomyoma; Lidocaine; Middle Aged; Pain, Po | 2008 |
Preoperative analgesia with local lidocaine infiltration for abdominal hysterectomy pain management.
Topics: Adult; Anesthetics, Local; Female; Humans; Hysterectomy; Leiomyoma; Lidocaine; Middle Aged; Pain, Po | 2008 |
Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata.
Topics: Analgesia, Patient-Controlled; Anesthetics, Local; Double-Blind Method; Embolization, Therapeutic; F | 2001 |
7 other studies available for lidocaine and Cancer of the Uterus
| Article | Year |
|---|---|
Intra-Arterial Lidocaine Administration for Anesthesia after Uterine Artery Embolization with Trisacryl Gelatin Microspheres for Leiomyoma.
Topics: Acrylic Resins; Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Local; Drug A | 2020 |
Ultrasound guided erector spinae plane block as a cause of unintended motor block.
Topics: Adult; Analgesia, Obstetrical; Bupivacaine; Cesarean Section; Diffusion; Female; Gait Disorders, Neu | 2018 |
[Pain control with epidural anesthesia for uterine artery embolization].
Topics: Adult; Amides; Analgesia, Epidural; Anti-Inflammatory Agents, Non-Steroidal; Arteries; Embolization, | 2004 |
Localized clonic convulsions after spinal anesthesia with lidocaine and epinephrine.
Topics: Anesthesia, Spinal; Epinephrine; Female; Humans; Hydatidiform Mole; Hysterectomy; Lidocaine; Middle | 1982 |
Acquired methemoglobinemia from multiple oxidants.
Topics: Administration, Topical; Adult; Analgesia, Epidural; Blood Gas Analysis; Bupivacaine; Cytochrome-B(5 | 1993 |
[Use of xylocaine in placing afterloading applicators in the gynecologic area--a simplified and analgesic method].
Topics: Anesthesia, Local; Brachytherapy; Female; Humans; Lidocaine; Pain Measurement; Uterine Cervical Neop | 1992 |
Clinical applications of the wing sound device.
Topics: Adult; Biopsy; Cervix Uteri; Endometrium; Female; Follow-Up Studies; Genital Diseases, Female; Gynec | 1974 |